--- title: Cord Blood vs. Other FDA-Approved Stem Cell Sources date: 2026-07-09T12:31:00-04:00 author: Jairah Said canonical_url: "https://www.americordblood.com/articles/cord-blood-vs-other-fda-approved-stem-cell-sources" section: Articles --- ![6a496f79f6643716137b9bd5 1783198999642](https://assets.americordblood.com/transforms/blogs/6143713/6a496f79f6643716137b9bd5-1783198999642_dcd4b851eab0fdc82c7554dc6e8ca81c.jpg) [ Treatments & Clinical Trials ](https://www.americordblood.com/articles/treatments-clinical-trials) 8 Min Read # Cord Blood vs. Other FDA-Approved Stem Cell Sources **If you want stem cells that can be stored *before* there is ever a medical need, cord blood is the only option.** Bone marrow and peripheral blood are both used in transplant care too, but they depend on finding a donor, setting up collection, and waiting for the process to happen. Here’s the short version: - **Cord blood** is collected **once at birth**, stored ahead of time, and can be used with a [**looser HLA match**](https://www.americordblood.com/articles/hla-typing-and-stem-cell-transplants). - **Bone marrow** has a long track record, but collection needs **surgery and anesthesia** for the donor. - **Peripheral blood stem cells** often lead to the **fastest engraftment** because they contain **2 to 3 times more CD34+ cells** than a usual bone marrow harvest. - The tradeoff: **cord blood engrafts more slowly** (**25–38 days**) than bone marrow (**14–19 days**) or peripheral blood (**14–16 days**). - On the other hand, **chronic graft-versus-host disease (GVHD)** is **lowest with cord blood** at about **16%**, versus **28%** for bone marrow and **29%** for peripheral blood. - In plain terms: if timing and access matter most, [**cord blood banking benefits**](https://www.americordblood.com/articles/cord-blood-banking-benefits) **stand apart** because it is already collected and stored. ## Quick Comparison SourceHow it’s collectedMatch needEngraftmentDonor burdenWhen it’s available**Cord blood**Collected after birth from the cord and placentaLower, often **4/6 or 5/6 HLA**Slowest: **25–38 days**None for the baby**Immediate if banked**[**Bone marrow**](https://www.americordblood.com/articles/bone-marrow-vs-cord-blood)Surgical collection from the hip boneHigher, often **8/8 or 10/10 HLA****14–19 days**High**Weeks to months****Peripheral blood**G-CSF shots for **4–5 days**, then apheresisHigher, often **8/8 or 10/10 HLA**Fastest: **14–16 days**Moderate**Weeks to months**If I boil the whole topic down to one point, it’s this: **cord blood is the only stem cell source families can choose and store before birth**, and that timing is what makes this decision different from the other two. For many, understanding these differences is the first step in deciding [if cord blood banking is worth it](https://www.americordblood.com/articles/is-cord-blood-banking-worth-it) for their family. ## The 3 Main FDA-Approved Stem Cell Sources These three sources differ most in **how the cells are collected**, **what the donor has to go through**, and **how fast the transplant may start working**. That’s the practical split. Some methods ask more of the donor. Some can be used when timing is tight. And some tend to lead to faster engraftment. ### Cord Blood: Blood-Forming Stem Cells Collected at Birth Cord blood comes from the umbilical cord and placenta after birth. It is a blood-forming stem cell source often used when a close HLA match is not available. There’s one big catch: collection happens only once. So families need to decide *before delivery* if they want to keep that option open. Because cord blood can still be useful when the match is not perfect, it can play an important role when transplant timing matters. ### Bone Marrow: A Long-Standing Source for Transplants Bone marrow has been used in HSCT for decades, especially in **pediatric patients and cases involving non-malignant conditions** like aplastic anemia. In this method, blood-forming stem cells are taken from the spongy tissue inside the back of the hip bone. The process is surgical and requires anesthesia. That means the donor takes on more burden than with cord blood collection. ### Peripheral Blood Stem Cells: Mobilized Cells Collected by Apheresis With peripheral blood stem cells, donors first receive **granulocyte colony-stimulating factor (G-CSF)**. This moves stem cells from the bone marrow into the bloodstream. After that, the cells are collected through apheresis. There’s no surgery, which is a big difference from bone marrow donation. Still, donors need several days of G-CSF injections before collection. PBSCs contain **2 to 3 times more CD34+ cells** than a typical bone marrow harvest, and that leads to faster engraftment. That faster start is a big reason PBSCs are the most common source for adult donor transplants. Here is the direct side-by-side view. FeatureCord BloodBone MarrowPeripheral Blood**Where cells come from**Umbilical cord and placentaSpongy tissue inside bonesBloodstream after mobilization**Collection method**Non-invasive drainageSurgical aspirationApheresis**Anesthesia needed**NoneLocal or generalNone**Preparation time**Collected at birthScheduled procedure4–5 days of G-CSF injections**Engraftment speed**SlowerModerateFastest**Primary clinical use**Alternative when a perfect match isn't availablePediatrics; non-malignant diseaseAdult malignancies## Cord Blood vs. Bone Marrow vs. Peripheral Blood: A Direct Comparison The day-to-day differences come down to three things: **how the cells are collected, how close the HLA match needs to be, and how fast the source can be used**. FeatureCord BloodBone MarrowPeripheral Blood Stem Cells**Collection Method**Non-invasive (at birth)Surgical aspiration from the iliac crest (hip bone)Apheresis after mobilization**Typical HLA match needed**Low (4/6 or 5/6 HLA)High (8/8 or 10/10 HLA)High (8/8 or 10/10 HLA)**Chronic graft-versus-host disease risk**Lowest (~16%)Moderate (~28%)Highest (~29%)**Time to neutrophil engraftment**Slowest (25–38 days)14–19 days14–16 days**Availability**Immediate (if banked)Weeks to monthsWeeks to months**Donor Burden**NoneHigh (surgery/anesthesia)Moderate (injections/apheresis)### Collection Method, Donor Burden, and Timing For parents thinking about [newborn stem cell banking](https://www.americordblood.com/newborn-stem-cells-101), **availability is the biggest split between these sources**. Cord blood is collected from material that would normally be discarded after delivery. There is **no donor procedure** and no extra burden on the baby. Bone marrow is very different. It requires surgical aspiration from the hip bone under anesthesia. Peripheral blood stem cells skip surgery, but the donor still needs 4–5 days of G-CSF injections before apheresis. Timing matters too. Cord blood can be used **right away once banked**. Bone marrow and peripheral blood usually take longer because they depend on donor search, coordination, and scheduling. In practice, that can mean weeks to months. ### HLA Matching, GVHD Risk, and Transplant Outcomes Cord blood can work with a looser HLA match. That matters a lot for patients who can't find a close donor match through family or registries. The tradeoff is speed. Cord blood has the slowest neutrophil engraftment, at **25–38 days**, compared with **14–19 days** for bone marrow and **14–16 days** for peripheral blood stem cells. Slower engraftment can mean a higher early infection risk. There’s another side to that tradeoff: **chronic graft-versus-host disease risk is lowest with cord blood**, at about **16%**. Bone marrow comes in at **28%**, and peripheral blood at **29%**. Long-term survival is similar in AML after two disease-free years. That mix of looser matching, immediate availability, and lower chronic GVHD risk helps explain why cord blood can stand out when families want an option in place before birth. ## Where Cord Blood Stands Out for Families Planning Ahead The comparison above points to real tradeoffs between cord blood, bone marrow, and peripheral blood stem cells. But for families deciding before a baby is born, the main question is often much simpler: **what will actually be there if a transplant is ever needed?** ### Ready Access and Flexibility in Transplant Care Banked cord blood has already been collected, processed, and stored. That means it is ready for use when needed. For families, cord blood is the only source that can be preserved *before* there is ever a medical need. ### Why Some Families Choose Newborn Stem Cell Banking That timing is a big reason some parents choose to bank cord blood at birth. After delivery, cord blood is collected from the umbilical cord and placenta and stored for future use. It can be a practical option for siblings and other relatives, and related-donor cord blood may improve access for family use. The catch is simple: planning has to happen before delivery. ACOG suggests getting a [cord blood collection kit](https://www.americordblood.com/articles/why-the-americord-collection-kit-is-better) at least six weeks before the due date. Families are also encouraged to finalize plans by week 34 of pregnancy so everything is ready before labor begins. ## Conclusion: Key Differences to Know Before Birth The choice comes down to three things: **timing**, **match flexibility**, and [**how fast the cells engraft**](https://www.americordblood.com/articles/the-difference-between-hematopoietic-and-mesenchymal-stem-cells). Each source has its own tradeoffs. Bone marrow requires invasive surgery under anesthesia. Peripheral blood calls for several days of injections before apheresis and carries the highest risk of chronic GVHD. Cord blood is different. It’s collected non-invasively at birth and, once banked, it’s available right away without the need for a donor search. For families planning before birth, cord blood is the only source that can be stored ahead of time. And for families thinking about [banking cord blood, tissue, and placenta](https://www.americordblood.com/articles/should-i-bank-cord-blood-tissue-and-placenta-tissue), the main upside is pretty simple: **collect it once, store it early, and have it ready if it’s ever needed**. ## FAQs ### Who can use banked cord blood? Banked cord blood is meant for the child it came from. It may also be used by first- or second-degree relatives. These hematopoietic stem cells are a **100% genetic match** for the donor child, and they may also be a match for siblings. When cord blood is donated to a public bank, it’s stored so it can be used by anyone who needs a transplant. ### Why does cord blood need a looser match? Cord blood needs less strict **HLA matching** because its stem cells are more immunologically naive and immature than the ones found in adult bone marrow. Put simply, these cells have less-developed immune markers, which lowers the risk of **graft-versus-host disease (GVHD)**. That’s why cord blood transplants can often succeed even with a partial mismatch. Bone marrow transplants, on the other hand, usually require a much closer genetic match. ### When should parents decide to bank cord blood? Parents need to make this choice **before childbirth**. That’s because cord blood can only be collected right after birth. The collection itself is simple. It’s quick, non-invasive, and painless, and it usually takes **5 to 10 minutes** after the umbilical cord is clamped and cut. Once the cord blood is collected, the sample needs to be processed and cryopreserved within **48 hours** to help maintain viability. *The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.* ### Advanced Family Plan More stem cells types (HSCs & MSCs) means more protection for your new family. [ View Service ](https://www.americordblood.com/advanced-family-plan) ### Simple, Straight Forward Pricing At Americord, we provide the highest-quality stem cell processing and the lowest storage rates in the industry. Discover which payment plan is best for you! [ View Service ](https://www.americordblood.com/pricing) ### Be the First to Know Never miss the latest cord blood breakthrough, clinical trial, or stem cell education to keep your family healthy for life. Sign Up Share [ ](https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcord-blood-vs-other-fda-approved-stem-cell-sources "Facebook") [ ](https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcord-blood-vs-other-fda-approved-stem-cell-sources "LinkedIn") [ ](mailto:?body=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcord-blood-vs-other-fda-approved-stem-cell-sources "Email") ## Related Articles [ ![69949617efc60cc2af07e4a6 1771349855248](https://assets.americordblood.com/transforms/blogs/4851423/69949617efc60cc2af07e4a6-1771349855248_2026-02-18-164909_tkdn_41a4f2ed037c5ad51696884668d44cc6.jpg) ](https://www.americordblood.com/articles/stem-cells-support-personalized-medicine) [### How Stem Cells Support Personalized Medicine ](https://www.americordblood.com/articles/stem-cells-support-personalized-medicine)How patient-derived stem cells enable disease modeling, drug testing, gene editing and regenerative therapies—and why newborn stem cell banking matters. [ Read More ](https://www.americordblood.com/articles/stem-cells-support-personalized-medicine) [ ![69f9362474a8318574a4fdac 1777974319292](https://assets.americordblood.com/transforms/blogs/5600971/69f9362474a8318574a4fdac-1777974319292_2026-05-07-211427_fumh_41a4f2ed037c5ad51696884668d44cc6.jpg) ](https://www.americordblood.com/articles/allogeneic-vs-autologous-stem-cell-treatments) [### Allogeneic vs. Autologous Stem Cell Treatments ](https://www.americordblood.com/articles/allogeneic-vs-autologous-stem-cell-treatments)Compare autologous vs allogeneic stem cell transplants: risks, benefits, recovery, donor matching, and cord blood banking. [ Read More ](https://www.americordblood.com/articles/allogeneic-vs-autologous-stem-cell-treatments) [ ![6993e802efc60cc2af07d098 1771303007202](https://assets.americordblood.com/transforms/blogs/4840468/6993e802efc60cc2af07d098-1771303007202_2026-02-17-173926_mpwi_41a4f2ed037c5ad51696884668d44cc6.jpg) ](https://www.americordblood.com/articles/future-of-autoimmune-stem-cell-therapies) [### Future of Autoimmune Stem Cell Therapies ](https://www.americordblood.com/articles/future-of-autoimmune-stem-cell-therapies)Overview of MSC and HSCT advances, gene editing and CAR technologies, clinical trial progress, risks, and cell banking for future autoimmune treatments. [ Read More ](https://www.americordblood.com/articles/future-of-autoimmune-stem-cell-therapies)